Literature DB >> 8736519

The role of 99Tcm-HMPAO brain SPET in paediatric traumatic brain injury.

E Goshen1, S T Zwas, E Shahar, R Tadmor.   

Abstract

Twenty-eight paediatric patients suffering from chronic sequelae of traumatic brain injury (TBI) were examined by EEG, radionuclide imaging with 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HMPAO), computed tomography (CT) and, when available, magnetic resonance imaging (MRI), the results of which were evaluated retrospectively. Our findings indicate that neuro-SPET (single photon emission tomography) with 99Tcm-HMPAO is more sensitive than morphological or electrophysiological tests in detecting functional lesions. In our group, 15 of 32 CT scans were normal, compared with 3 of 35 SPET studies. SPET identified approximately 2.5 times more lesions than CT (86 vs 34). SPET was found to be particularly sensitive in detecting organic abnormalities in the basal ganglia and cerebellar regions, with a 3.6:1 detection rate in the basal ganglia and a 5:1 detection rate in the cerebellum compared with CT. In conclusion, neuro-SPET appears to be very useful when evaluating paediatric post-TBI patients in whom other modalities are not successful.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8736519     DOI: 10.1097/00006231-199605000-00011

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  9 in total

Review 1.  Imaging of accidental paediatric head trauma.

Authors:  Phua Hwee Tang; Choie Cheio Tchoyoson Lim
Journal:  Pediatr Radiol       Date:  2009-01-06

2.  Loss of neuronal integrity: a cause of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage.

Authors:  Tohru Shiga; Katsunori Ikoma; Chietsugu Katoh; Hirotaka Isoyama; Tetsuaki Matsuyama; Yuji Kuge; Hiroyuki Kageyama; Tomoya Kohno; Satoshi Terae; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-25       Impact factor: 9.236

3.  Brain SPECT Imaging in Complex Psychiatric Cases: An Evidence-Based, Underutilized Tool.

Authors:  Daniel G Amen; Manuel Trujillo; Andrew Newberg; Kristen Willeumier; Robert Tarzwell; Joseph C Wu; Barry Chaitin
Journal:  Open Neuroimag J       Date:  2011-07-28

4.  Post traumatic brain perfusion SPECT analysis using reconstructed ROI maps of radioactive microsphere derived cerebral blood flow and statistical parametric mapping.

Authors:  Anthony J McGoron; Michael Capille; Michael F Georgiou; Pablo Sanchez; Juan Solano; Manuel Gonzalez-Brito; John W Kuluz
Journal:  BMC Med Imaging       Date:  2008-02-29       Impact factor: 1.930

5.  I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury.

Authors:  Kagari Abiko; Katsunori Ikoma; Tohru Shiga; Chietsugu Katoh; Kenji Hirata; Yuji Kuge; Kentaro Kobayashi; Nagara Tamaki
Journal:  EJNMMI Res       Date:  2017-03-23       Impact factor: 3.138

6.  Clinical comparison of 99mTc exametazime and 123I Ioflupane SPECT in patients with chronic mild traumatic brain injury.

Authors:  Andrew B Newberg; Mijail Serruya; Andrew Gepty; Charles Intenzo; Todd Lewis; Daniel Amen; David S Russell; Nancy Wintering
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

Review 7.  Clinical utility of SPECT neuroimaging in the diagnosis and treatment of traumatic brain injury: a systematic review.

Authors:  Cyrus A Raji; Robert Tarzwell; Dan Pavel; Howard Schneider; Michael Uszler; John Thornton; Muriel van Lierop; Phil Cohen; Daniel G Amen; Theodore Henderson
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

8.  Nuclear Medicine Imaging in Pediatric Neurology.

Authors:  Ümit Özgür Akdemir; Lütfiye Özlem Atay Kapucu
Journal:  Mol Imaging Radionucl Ther       Date:  2016-02-05

9.  A New Way Forward: How Brain SPECT Imaging Can Improve Outcomes and Transform Mental Health Care Into Brain Health Care.

Authors:  Daniel G Amen; Michael Easton
Journal:  Front Psychiatry       Date:  2021-12-10       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.